logo
15:59 Dec 05

Orchid Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
867.70
+2.55 (+0.29%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Orchid Pharma Ltd. Financials

Orchid Pharma Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
867.70
+2.55 (+0.29%)
15:59 Dec 05
Quality
image/svg+xml

41/100
Medium Financial Strength

Valuation
image/svg+xml

27/100
Expensive Valuation

Technical

57/100
Technically Neutral

Strength

6

Weakness

9

Opportunity

1

Threats

2

7.86 %

ROE %

5.90 %

ROA %

10.30

EPS

249.86

BVPS

10.80 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
559.56 665.9 819.37 921.93 850.45
Operating Expenses +
506.43 582.27 708.7 804.75 751.59
Raw Material
340.62 406.1 528.35 588.07 546.24
Increase Decrease in Cost
-27.06 -21.48 -43.89 -43.85 -53.41
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
63.28 65.35 69.64 86.36 85.97
Miscellaneous Expenses
129.59 132.3 154.6 179.39 172.79
Operating Profit
53.13 83.63 110.67 117.18 98.86
Other Income
9 19.43 30.86 27.47 31.36
Depreciation
87.02 54.79 33.24 34.55 34.75
Interest
32.01 32.23 16.35 14.54 14.31
Profit before tax and exceptio..
-56.9 16.04 91.95 95.56 81.16
Exceptional Items
0 39.21 0 0 0
PBT
-56.9 55.25 91.95 95.56 81.16
Provision for Taxation
0 0 -3.12 -0.19 -0.04
Net Profit
1.57 48.47 95.06 95.76 81.19
NET Profit after MI
-1.95 46.32 92.17 99.66 85.22
EPS
-0.48 11.35 19.06 19.65 16.81
Operating Profit Margin (%)
9.5 12.56 13.51 12.71 11.62
Net Profit Margin (%)
-0.35 6.96 11.25 10.81 10.02

Orchid Pharma Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 69.80 69.80 69.80 69.80 69.80 69.80
FII 1.60 1.40 2.70 2.50 1.90 1.40
Public 19.00 19.40 20.10 19.00 18.30 19.00
Others 9.60 9.40 7.40 8.70 10.00 9.80
Shareholder Shares Holding %
Research 360 logo
Download Our App On: